IL6 and rheumatoid arthritis: In RA, inflammatory cytokines including tumor necrosis factor (TNF)-α, interleukin (IL)-1β, and IL-6, have been found to enhance RANKL expression in synovial fibroblasts, which subsequently activates osteoclasts in joints [6]–[8].